ChemoMetec A/S Stock

Equities

CHEMM

DK0060055861

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe Europe 05:07:34 2024-04-23 am EDT 5-day change 1st Jan Change
283.5 DKK -1.01% Intraday chart for ChemoMetec A/S -7.57% -26.39%
Sales 2024 * 404M 57.57M Sales 2025 * 471M 67.15M Capitalization 4.98B 711M
Net income 2024 * 134M 19.12M Net income 2025 * 157M 22.4M EV / Sales 2024 * 11.5 x
Net cash position 2024 * 343M 48.92M Net cash position 2025 * 403M 57.56M EV / Sales 2025 * 9.73 x
P/E ratio 2024 *
37.2 x
P/E ratio 2025 *
31.8 x
Employees 171
Yield 2024 *
2.27%
Yield 2025 *
2.79%
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.61%
1 week-6.41%
Current month-31.76%
1 month-31.95%
3 months-22.42%
6 months+5.55%
Current year-25.46%
More quotes
1 week
282.20
Extreme 282.2
315.00
1 month
282.20
Extreme 282.2
427.00
Current year
282.20
Extreme 282.2
554.00
1 year
255.00
Extreme 255
554.00
3 years
255.00
Extreme 255
1 149.00
5 years
134.00
Extreme 134
1 149.00
10 years
3.26
Extreme 3.26
1 149.00
More quotes
Managers TitleAgeSince
Founder 65 96-12-31
Director of Finance/CFO - 22-10-31
Chief Tech/Sci/R&D Officer - 07-08-31
Members of the board TitleAgeSince
Director/Board Member 62 14-09-30
Founder 65 96-12-31
Director/Board Member 48 -
More insiders
Date Price Change Volume
24-04-23 285.6 -0.28% 11 027
24-04-22 286.4 +0.42% 65,122
24-04-19 285.2 -0.83% 84,328
24-04-18 287.6 -3.36% 136,700
24-04-17 297.6 -3.69% 260,889

Delayed Quote Nasdaq Copenhagen, April 23, 2024 at 03:09 am EDT

More quotes
Chemometec A/S is a Denmark-based company engaged in the development, manufacture and sale of analytical instruments used for quantitative analysis of cells in liquids. The Company’s activities are divided into three business areas: Instruments, which offers a range of NucleoCounter analytical instruments for counting mammalian, animal, yeast and sperm cells, as well as somatic cells in milk, among others; Consumables, which distributes disposable cassettes, solutions, reagents and slides; and Other, which is responsible for the partnership development in a number of research projects, among others. The Company’s analytical products are based on a technology, which combines fluorescence microscopy with digital imagery. Its customer portfolio comprises entities active primarily within pharmaceutical, food processing and agriculture industries. Furthermore, the Company is a parent of ChemoMetec USA Inc.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
286.4 DKK
Average target price
462.5 DKK
Spread / Average Target
+61.49%
Consensus